Table 5.
Groups | n | FINS (mIU/L) | FBG (mmol/L) | HOMA-IR |
---|---|---|---|---|
Control | 8 | 16.51 ± 3.11∗∗ | 2.88 ± 0.27∗∗ | 2.10 ± 0.38∗∗ |
Model | 8 | 36.20 ± 5.68 | 5.58 ± 0.21 | 8.96 ± 1.36 |
Salidroside | 8 | 26.93 ± 4.88∗∗ | 4.31 ± 0.65∗∗ | 5.18 ± 1.32∗∗ |
Rosiglitazone | 8 | 25.22 ± 2.98∗∗ | 4.22 ± 0.59∗∗ | 4.74 ± 0.96∗∗ |
∗∗P < 0.01 versus model group.